Amoryn supplement claims review
This article was originally published in The Tan Sheet
Executive Summary
Bioneurix provides a reasonable basis for general performance claims for its Amoryn dietary supplement in treating mild to moderate depression, however, evidence presented by the marketer does not support claims that the product's main ingredient, hyperforin, has been clinically proven to treat "severe" depression, according to the Electronic Retailing Self-Regulation Program. The Council of Better Business Bureaus program commenced the review of online claims as part of its ongoing monitoring efforts. Costa Mesa, Calif.-based Bioneurix said it would take the recommendations into consideration for future ads and has already taken steps to change some wording on its Web site
|
Bioneurix provides a reasonable basis for general performance claims for its Amoryn dietary supplement in treating mild to moderate depression, however, evidence presented by the marketer does not support claims that the product's main ingredient, hyperforin, has been clinically proven to treat "severe" depression, according to the Electronic Retailing Self-Regulation Program. The Council of Better Business Bureaus program commenced the review of online claims as part of its ongoing monitoring efforts. Costa Mesa, Calif.-based Bioneurix said it would take the recommendations into consideration for future ads and has already taken steps to change some wording on its Web site. |